Finder USA

Finder is a medical technology company specializing in point-of-care molecular diagnostics for infectious diseases. The company's flagship Finder platform is a compact, automated system designed to provide lab-quality results in under 20 minutes in decentralized settings such as clinics, pharmacies, and homes. By integrating advanced microfluidics with molecular biology, Finder aims to bridge the gap between slow laboratory PCR tests and less sensitive rapid antigen tests. The company gained significant recognition through its participation in the NIH's Rapid Acceleration of Diagnostics (RADx) initiative, which supported the development and scale-up of its high-throughput respiratory testing solutions.